Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

The British Association for Psychopharmacology (BAP) coordinated a meeting of experts to review the evidence on the drug treatment for dementia. The level of evidence (types) was rated using a standard system: Types 1a and 1b (evidence from meta-analysis of randomised controlled trials or at least o...

Full description

Bibliographic Details
Main Authors:	Burns, A, O'Brien, J, Auriacombe, S, Ballard, C, Broich, K, Bullock, R, Feldman, H, Ford, G, Knapp, M, McCaddon, A, Iliffe, S, Jacova, C, Jones, R, Lennon, S, McKeith, I, Orgogozo, J, Purandare, N, Richardson, M, Ritchie, C, Thomas, A, Warner, J, Wilcock, G, Wilkinson, D
Format:	Journal article
Language:	English
Published:	2006

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Similar Items